Skip to main content

Belgium

20
Apr 2020

Belgian INAMI/RIZIV updated the List of reimbursable implants and medical devices

New material codes for a locking stylus for extraction of endovenous electrodes and system with recovery lasso for the extraction of endovenous electrodes by femoral approach were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in April 2020. Some reimbursement conditions were updated as well.
23
Mar 2020

Reimbursement for COVID-19 Detection Test in Belgium

Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) has issued an agreement document on March 17, 2020, providing principles for billing and funding the Coronavirus (COVID-19) Detection Tests. Previously in Protocol for Hospitals on March 10, 2020, it was outlined that COVID-19 tests performed outside the National Reference Center for Respiratory Pathogens at UZ Leuven have no specific nomenclature codes, and no reimbursement was provided, therefore, was paid by patients. The new agreement clarifies principles for reimbursement, but the invoicing for the tests still on hold.